{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T22:37:37Z","timestamp":1787611057756,"version":"build-2736575974"},"reference-count":28,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Immunobiology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.imbio.2026.153163","type":"journal-article","created":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:04:12Z","timestamp":1770077052000},"page":"153163","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Unmodified \u03b3\u03b4 T cells exhibit potent antitumor activity in hepatocellular carcinoma and are enhanced by PD-L1 blockade"],"prefix":"10.1016","volume":"231","author":[{"given":"Bo-Xiang Benjamin","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Yi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoang Yen","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chung-Che","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-Yun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsung-I","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Jie","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.imbio.2026.153163_bb0005","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1038\/s41568-021-00363-z","article-title":"Interleukins in cancer: from biology to therapy","volume":"21","author":"Briukhovetska","year":"2021","journal-title":"Nat. Rev. Cancer"},{"issue":"20","key":"10.1016\/j.imbio.2026.153163_bb0010","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1056\/NEJMoa1915745","article-title":"Atezolizumab plus Bevacizumab in Unresectable Hepatocellular Carcinoma","volume":"382","author":"Finn","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"8","key":"10.1016\/j.imbio.2026.153163_bb0015","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1038\/s43018-023-00589-w","article-title":"Gammadelta T cell dichotomy with opposing cytotoxic and wound healing functions in human solid tumors","volume":"4","author":"Harmon","year":"2023","journal-title":"Nat. Cancer"},{"issue":"3","key":"10.1016\/j.imbio.2026.153163_bb0020","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/cmi.2015.112","article-title":"Modulation of liver tolerance by conventional and nonconventional antigen-presenting cells and regulatory immune cells","volume":"13","author":"Horst","year":"2016","journal-title":"Cell. Mol. Immunol."},{"issue":"1","key":"10.1016\/j.imbio.2026.153163_bb0025","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jhep.2019.08.014","article-title":"The immunobiology of hepatocellular carcinoma in humans and mice: basic concepts and therapeutic implications","volume":"72","author":"Hou","year":"2020","journal-title":"J. Hepatol."},{"issue":"4","key":"10.1016\/j.imbio.2026.153163_bb0030","doi-asserted-by":"crossref","first-page":"518","DOI":"10.3390\/jpm12040518","article-title":"Reappraisal of the Role of Alkaline Phosphatase in Hepatocellular Carcinoma","volume":"12","author":"Huang","year":"2022","journal-title":"J. Pers. Med."},{"key":"10.1016\/j.imbio.2026.153163_bb0035","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.intimp.2019.02.019","article-title":"Gammadelta T cells in hepatocellular carcinoma patients present cytotoxic activity but are reduced in potency due to IL-2 and IL-21 pathways","volume":"70","author":"Jiang","year":"2019","journal-title":"Int. Immunopharmacol."},{"issue":"1","key":"10.1016\/j.imbio.2026.153163_bb0040","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1111\/jgh.14005","article-title":"Environmental contributions to gastrointestinal and liver cancer in the Asia-Pacific region","volume":"33","author":"Ko","year":"2018","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.imbio.2026.153163_bb0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.jceh.2024.102406","article-title":"Evolving Global Etiology of Hepatocellular Carcinoma (HCC): Insights and Trends for 2024","volume":"15","author":"Koshy","year":"2025","journal-title":"J. Clin. Exp. Hepatol."},{"key":"10.1016\/j.imbio.2026.153163_bb0050","article-title":"Expansion and Enrichment of Gamma-Delta (gammadelta) T Cells from Apheresed Human Product","volume":"175","author":"Landin","year":"2021","journal-title":"J. Vis. Exp."},{"issue":"1","key":"10.1016\/j.imbio.2026.153163_bb0055","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/cas.16013","article-title":"T-cell receptor sequencing reveals hepatocellular carcinoma immune characteristics according to Barcelona Clinic liver cancer stages within liver tissue and peripheral blood","volume":"115","author":"Li","year":"2024","journal-title":"Cancer Sci."},{"key":"10.1016\/j.imbio.2026.153163_bb0060","article-title":"Immunotherapy in liver cancer: overcoming the tolerogenic liver microenvironment","volume":"15","author":"Liu","year":"2024","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.imbio.2026.153163_bb0065","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1186\/s12967-024-05327-z","article-title":"Gammadelta T cells and the PD-1\/PD-L1 axis: a love-hate relationship in the tumor microenvironment","volume":"22","author":"Liu","year":"2024","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.imbio.2026.153163_bb0070","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s41572-020-00240-3","article-title":"Hepatocellular carcinoma","volume":"7","author":"Llovet","year":"2021","journal-title":"Nat. Rev. Dis. Primers"},{"key":"10.1016\/j.imbio.2026.153163_bb0075","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.3389\/fimmu.2018.01395","article-title":"Gammadelta T Cells and Tumor Microenvironment: from Immunosurveillance to Tumor Evasion","volume":"9","author":"Lo Presti","year":"2018","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.imbio.2026.153163_bb0080","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1053\/j.gastro.2020.01.032","article-title":"Knockdown of Virus Antigen Expression increases Therapeutic Vaccine Efficacy in High-Titer Hepatitis B Virus carrier mice","volume":"158","author":"Michler","year":"2020","journal-title":"Gastroenterology"},{"issue":"1","key":"10.1016\/j.imbio.2026.153163_bb0085","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1136\/gutjnl-2021-325918","article-title":"Inflamed and non-inflamed classes of HCC: a revised immunogenomic classification","volume":"72","author":"Montironi","year":"2023","journal-title":"Gut"},{"issue":"6506","key":"10.1016\/j.imbio.2026.153163_bb0090","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1126\/science.aay2767","article-title":"BTN3A1 governs antitumor responses by coordinating alphabeta and gammadelta T cells","volume":"369","author":"Payne","year":"2020","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.imbio.2026.153163_bb0095","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/s41571-021-00588-9","article-title":"Harnessing cytokines and chemokines for cancer therapy","volume":"19","author":"Propper","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"issue":"27","key":"10.1016\/j.imbio.2026.153163_bb0100","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1200\/JCO.21.00163","article-title":"Donafenib Versus Sorafenib in First-Line Treatment of Unresectable or Metastatic Hepatocellular Carcinoma: a Randomized, Open-Label, Parallel-Controlled phase II-III Trial","volume":"39","author":"Qin","year":"2021","journal-title":"J. Clin. Oncol."},{"issue":"6382","key":"10.1016\/j.imbio.2026.153163_bb0105","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1126\/science.aar4060","article-title":"Cancer immunotherapy using checkpoint blockade","volume":"359","author":"Ribas","year":"2018","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.imbio.2026.153163_bb0110","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/s41575-021-00438-0","article-title":"Advances in immunotherapy for hepatocellular carcinoma","volume":"18","author":"Sangro","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"issue":"3","key":"10.1016\/j.imbio.2026.153163_bb0115","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1038\/s41573-019-0038-z","article-title":"Translating gammadelta (gammadelta) T cells and their receptors into cancer cell therapies","volume":"19","author":"Sebestyen","year":"2020","journal-title":"Nat. Rev. Drug Discov."},{"issue":"10360","key":"10.1016\/j.imbio.2026.153163_bb0120","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/S0140-6736(22)01200-4","article-title":"Hepatocellular carcinoma","volume":"400","author":"Vogel","year":"2022","journal-title":"Lancet"},{"issue":"10","key":"10.1016\/j.imbio.2026.153163_bb0125","doi-asserted-by":"crossref","first-page":"8944","DOI":"10.3390\/ijms24108944","article-title":"The Role of Inflammation in Age-Associated changes in Red Blood System","volume":"24","author":"Wacka","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.imbio.2026.153163_bb0130","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/s41392-023-01646-7","article-title":"Anti-PD-1 antibody armored gammadelta T cells enhance anti-tumor efficacy in ovarian cancer","volume":"8","author":"Wang","year":"2023","journal-title":"Signal Transduct. Target. Ther."},{"issue":"9","key":"10.1016\/j.imbio.2026.153163_bb0135","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1016\/j.ccell.2024.08.007","article-title":"Combination anti-PD-1 and anti-CTLA-4 therapy generates waves of clonal responses that include progenitor-exhausted CD8(+) T cells","volume":"42","author":"Wang","year":"2024","journal-title":"Cancer Cell"},{"issue":"8","key":"10.1016\/j.imbio.2026.153163_bb0140","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1007\/s00262-020-02561-4","article-title":"Energy metabolism and cell motility defect in NK-cells from patients with hepatocellular carcinoma","volume":"69","author":"Zecca","year":"2020","journal-title":"Cancer Immunol. Immunother."}],"container-title":["Immunobiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298526000094?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0171298526000094?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T05:03:57Z","timestamp":1773810237000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0171298526000094"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S0171298526000094"],"URL":"https:\/\/doi.org\/10.1016\/j.imbio.2026.153163","relation":{},"ISSN":["0171-2985"],"issn-type":[{"value":"0171-2985","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unmodified \u03b3\u03b4 T cells exhibit potent antitumor activity in hepatocellular carcinoma and are enhanced by PD-L1 blockade","name":"articletitle","label":"Article Title"},{"value":"Immunobiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.imbio.2026.153163","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"153163"}}